Datadog Stock Looks Undervalued
From retailers to healthcare providers, companies are now building digital backbones that need to run non-stop 24/7, 365 days a year. But keeping those systems humming without hiccups? That’s where Datadog steps in.
Datadog (NASDAQ: DDOG) makes cloud infrastructure monitoring software that acts like a digital nervous system for enterprises. If something breaks,
» Read more about: Datadog Stock Looks Undervalued »
Read More
1 Top Trader Just Bought Netflix
Is Netflix breaking out? If you are to believe Mark Minervini, a renowned trader with a very successful track record, the answer is yes, but there’s more to the story than meets the eye.
First let’s take a look out at the chart highlighting the recent breakout above resistance of Netflix. As you can see a few days ago the share price peeked above resistance,
» Read more about: 1 Top Trader Just Bought Netflix »
Read More
Hidden Gem in China’s Fintech Market?
Yiren Digital is likely not a company you have heard of but in China it has been growing like a weed thanks to two primary fintech offerings: CreditTech and Wealth Management.
With the rapid growth of China’s fintech sector and the increasing demand for digital financial services, Yiren Digital has been putting up numbers that demand a closer look.
» Read more about: Hidden Gem in China’s Fintech Market? »
Read More
Oh, That Can’t Be Good
Usually, we talk about interesting stocks that may be on the cusp of growing revenues, profits or share price rapidly on a Tuesday but today we’re breaking from our regular programming to flag a major concern that could affect consumers. And because consumer spending is widely regarded to constitute about 70% of GDP, anything that affects it has a material impact on the broader stock market.
» Read more about: Oh, That Can’t Be Good »
Read More
Wall Street Might Be Sleeping on Nvidia, But Not for Long
Nvidia’s stock has taken a notable dip in 2025, falling roughly 14% year-to-date. That slide has little to do with the company’s financials and everything to do with factors outside its control.
Fresh U.S. export restrictions on advanced chips, escalating trade war tensions, and worries that the boom in AI spending might cool off have all weighed on investor sentiment.
» Read more about: Wall Street Might Be Sleeping on Nvidia, But Not for Long »
Read MoreThe Ivy
4% Dividend + 12x Earnings = Blockbuster in the Making
Merck has long been a pillar of stability in the pharmaceutical world, thanks in large part to the staggering success of its cancer drug Keytruda. But behind that success lies a quietly growing concern of what happens when the patents expire?
In a move that could reshape its future, Merck just announced a $10 billion acquisition of Verona Pharma.
» Read more about: 4% Dividend + 12x Earnings = Blockbuster in the Making »
Read MoreThe Spotlight
Why Is Buffett Pouring Into This High Yield Bet
2024 has been a surprising year for Warren Buffett and Berkshire Hathaway. The company became the first American business outside of the tech sector to achieve a $1 trillion valuation, and an unusually buoyant stock market has caused many of its holdings to gain substantially in value.
Despite these successes, Buffett personally appears to be turning bearish.
» Read more about: Why Is Buffett Pouring Into This High Yield Bet »
Read MoreThe Daily
Cathie Wood sells over 38K Palantir shares before earnings
Key Takeaways
- Cathie Wood’s ARK Invest sold over 38,000 Palantir shares before earnings, reallocating funds to Bullish and Beam Therapeutics.
- The shift reflects ARK’s broader strategy to balance exposure between AI, crypto, and biotech sectors.
Share this article
Cathie Wood,
» Read more about: Cathie Wood sells over 38K Palantir shares before earnings »